Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion.
Osteoprotegerin (OPG), a decoy receptor for receptor activator of NF-κB ligand (RANKL), antagonizes RANKL's osteoclastogenic function in bone. We previously demonstrated that systemic administration of lipopolysaccharide (LPS) to mice elevates OPG levels and reduces RANKL levels in peripheral b...
Main Authors: | Yukiko Kuroda, Kenta Maruyama, Hideki Fujii, Isamu Sugawara, Shigeru B H Ko, Hisataka Yasuda, Hidenori Matsui, Koichi Matsuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4709133?pdf=render |
Similar Items
-
Placenta-Derived Osteoprotegerin Is Required for Glucose Homeostasis in Gestational Diabetes Mellitus
by: Binbin Huang, et al.
Published: (2020-09-01) -
Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms.
by: Batmunkh Bumdelger, et al.
Published: (2016-01-01) -
Osteoprotegerin in Cardiometabolic Disorders
by: C. Pérez de Ciriza, et al.
Published: (2015-01-01) -
Therapeutic implications of osteoprotegerin
by: Karalaki Maria, et al.
Published: (2009-09-01) -
The biological relevance of monomeric and dimeric osteoprotegerin
by: Coleman, Robert Charles
Published: (2009)